Downstream processing continues to be a huge, chronic pain point in biopharmaceutical manufacturing, as is evident from the data within BioPlan Associates’ 13th Annual Report and Survey of ...
What is the Key Component Driving the Downstream Processing Market? In this report, we uncover the key driving force behind the keyword market's expansion. We provide a detailed analysis of this ...
Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback